Limitation of (1→3)-β-D-glucan monitoring in major elective surgery involving cardiopulmonary bypass

Measuring (1->3)-beta-D-glucan has recently been advocated for detection of invasive candidiasis. Our data indicate that the rate of false positive results is potentially high in some patient collectives of risk, e.g. after cardiac artery bypass grafting.